Publication | Open Access
SNORA23 inhibits HCC tumorigenesis by impairing the 2'-O-ribose methylation level of 28S rRNA
31
Citations
27
References
2021
Year
SNORA23 exhibited antitumor effects in HCC and together with rapamycin, provided a promising therapeutic strategy for HCC treatment.
| Year | Citations | |
|---|---|---|
Page 1
Page 1